BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 17 filers reported holding BIOLINERX LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $27,000 | -86.2% | 61,205 | -72.7% | 0.00% | – |
| Q2 2018 | $195,000 | 0.0% | 224,399 | 0.0% | 0.00% | – |
| Q1 2018 | $195,000 | -58.9% | 224,399 | -48.4% | 0.00% | -100.0% |
| Q4 2017 | $474,000 | +56.4% | 434,700 | +60.9% | 0.00% | – |
| Q3 2017 | $303,000 | +140.5% | 270,200 | +105.5% | 0.00% | – |
| Q1 2017 | $126,000 | +186.4% | 131,480 | +389.2% | 0.00% | – |
| Q4 2014 | $44,000 | -77.7% | 26,878 | -79.0% | 0.00% | -100.0% |
| Q3 2014 | $197,000 | +116.5% | 128,100 | +193.1% | 0.00% | – |
| Q2 2014 | $91,000 | +51.7% | 43,700 | +63.1% | 0.00% | – |
| Q1 2014 | $60,000 | +106.9% | 26,800 | +162.7% | 0.00% | – |
| Q4 2013 | $29,000 | -78.5% | 10,200 | -83.4% | 0.00% | – |
| Q3 2013 | $135,000 | +181.2% | 61,600 | +106.3% | 0.00% | – |
| Q2 2013 | $48,000 | – | 29,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |